Early Short Course Corticosteroids in COVID-19
NCT04374071 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2020-05-05
Summary
The investigators intend to study the role of early use of methylprednisolone in the hospitalized patients with a diagnosis of COVID-19 pneumonia.
Conditions
- COVID
- Pneumonia, Viral
Interventions
- DRUG
-
Methylprednisolone
IV methylprednisolone 0.5 to 1 mg/kg/day in 2 divided doses for 3 days
Sponsors & Collaborators
-
Henry Ford Health System
lead OTHER
Principal Investigators
-
Mayur Ramesh · Henry Ford Health System
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-12
- Primary Completion
- 2020-03-27
- Completion
- 2020-04-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Corticosteroids for COVID-19
NCT04795583 ·Status: WITHDRAWN ·Phase: PHASE3
-
Individualizing Corticosteroid Use in Pneumonia
NCT05334316 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
NCT05844410 ·Status: COMPLETED
-
Early Treatment Strategy With High-dose Dexamethasone in Patients With SARS-CoV-2
NCT05293210 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine
NCT04654416 ·Status: COMPLETED
-
The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia
NCT04263402 ·Status: UNKNOWN ·Phase: PHASE4
-
Glucocorticoids in COVID-19 (CORTIVID)
NCT04438980 ·Status: COMPLETED ·Phase: PHASE3
-
NAC for Attenuation of COVID-19 Symptomatology
NCT05074121 ·Status: UNKNOWN ·Phase: PHASE2
-
Corticosteroids in Community Acquired Pneumonia
NCT04652414 ·Status: WITHDRAWN ·Phase: PHASE2
-
Corticosteroid Therapy for Severe Community-Acquired Pneumonia
NCT02552342 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia
NCT04451174 ·Status: TERMINATED ·Phase: PHASE3
-
Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury
NCT04341038 ·Status: UNKNOWN ·Phase: PHASE3
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)
NCT04409925 ·Status: COMPLETED ·Phase: PHASE1
-
Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients
NCT04674410 ·Status: WITHDRAWN
-
Study Testing Convalescent Plasma vs Best Supportive Care
NCT04333251 ·Status: WITHDRAWN ·Phase: PHASE1
-
P-Co-Li (Pulmonary Covid-19 Study)
NCT04782700 ·Status: WITHDRAWN ·Phase: NA
-
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
NCT04344288 ·Status: TERMINATED ·Phase: PHASE2
-
Steroid and Anticoagulant Therapy in covid19
NCT05021588 ·Status: COMPLETED ·Phase: NA
-
Use of Compromised Lung Volume in Monitoring Usage of Steroid Therapy on Severe COVID-19
NCT04953247 ·Status: COMPLETED
-
Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e)
NCT01283009 ·Status: COMPLETED ·Phase: PHASE3
-
Recovery of Respiratory System in COVID-19 Patients
NCT04954222 ·Status: COMPLETED
-
Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
NCT04371471 ·Status: COMPLETED
-
Colchicine Counteracting Inflammation in COVID-19 Pneumonia
NCT04322565 ·Status: COMPLETED ·Phase: PHASE2
-
Leflunomide in Mild COVID-19 Patients
NCT04361214 ·Status: TERMINATED ·Phase: PHASE1